In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response

Moel, E.C. de; Derksen, V.F.A.M.; Trouw, L.A.; Bang, H.; Collee, G.; Lard, L.R.; ... ; Woude, D. van der (2019)

Article / Letter to editor

• Rheumatoid arthritis
• Autoantibodies
• Ant-CCP2
• Rheumatoid factor
• Anti-carbamylated protein antibodies
• Disease activity
• Immunosuppression

• All authors: Moel, E.C. de; Derksen, V.F.A.M.; Trouw, L.A.; Bang, H.; Collee, G.; Lard, L.R.; Ramiro, S.; Huizinga, T.W.J.; Allaart, C.F.; Toes, R.E.M.; Woude, D. van der
• Date: 2019-01-18
• Journal: Arthritis Research and Therapy
• Volume: 21
• DOI: doi:10.1186/s13075-019-1815-0